Related Experiment Videos
SynergyFinder: a web application for analyzing drug combination dose-response matrix data.
Aleksandr Ianevski1, Liye He1, Tero Aittokallio1,2
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00290 Helsinki, Finland.
Bioinformatics (Oxford, England)
|April 6, 2017
Summary
A new web application, SynergyFinder, aids in analyzing cancer drug combinations. It helps researchers evaluate drug synergy and resistance, improving cancer treatment strategies.
Area of Science:
- Oncology
- Bioinformatics
- Pharmacology
Background:
- Drug resistance and sensitivity pose significant challenges in cancer treatment.
- Rational drug combination design is a key strategy to overcome these issues.
- Pre-clinical evaluation of pairwise drug combinations is crucial for therapeutic development.
Purpose of the Study:
- To develop a user-friendly web application for analyzing drug combination effects.
- To facilitate the systematic evaluation of pairwise drug combinations in cancer research.
- To provide flexible synergy scoring models and interactive visualization tools.
Main Methods:
- Implementation of the SynergyFinder R-package into a web application.
- Integration of multiple synergy scoring models for comprehensive analysis.
- Development of an interactive interface for visualizing drug combination landscapes.
Main Results:
- The SynergyFinder web application offers a flexible platform for analyzing drug combination data.
- It enables interactive visualization of drug synergy and combination effects.
- The tool supports multiple synergy scoring models for robust pre-clinical evaluation.
Conclusions:
- The SynergyFinder web application streamlines the analysis of drug combination experiments.
- It enhances the systematic evaluation of pre-clinical drug combinations for cancer therapy.
- This tool supports rational drug design to combat cancer drug resistance and sensitivity.